Dermatologists’ level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential

AlGhamdi, Khalid M.; Khurram, Huma; Asiri, Yousif A.; Mandil, Ahmed

doi:10.1111/j.1365-4632.2011.04875.x

Cited by 10 publications

(10 citation statements)

References 15 publications

(22 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A recent survey conducted among dermatologists in Saudi Arabia [25] showed also that some dermatologists are not compliant with recommendations for isotretinoin use in women of childbearing potential. This study is one of the few studies performed among dermatologists and the actual adherence to the PPP.…”

Section: Expert Opinionmentioning

confidence: 99%

Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study

Crijns¹,

Mantel‐Teeuwisse²,

Bloemberg³

et al. 2012

Expert Opinion on Drug Safety

View full text Add to dashboard Cite

show abstract

Section: Expert Opinionmentioning

confidence: 99%

Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study

Crijns¹,

Mantel‐Teeuwisse²,

Bloemberg³

et al. 2012

Expert Opinion on Drug Safety

View full text Add to dashboard Cite

show abstract

“…They did not provide them with adequate information about the teratogenic effect of isotretinoin. 11 Instead, certain papers revealed that the pharmacist educated the patients properly and provided them with sufficient knowledge to recognize the risks associated with their medication by using specific programs such as iPLEDGE. [12][13][14] There is a gap between the proven efficacy of isotretinoin capsules that are prescribed by a dermatologist in the clinic and their actual effectiveness in practice.…”

Section: Introductionmentioning

confidence: 99%

<p>Proper Counseling and Dispensing of Isotretinoin Capsule Products by Community Pharmacists in UAE: A Simulated Patient Study</p>

Rashid

Al-Tabakha

Alomar

2020

CCID

View full text Add to dashboard Cite

To evaluate the pharmacist's assessment of patient eligibility for safe use of isotretinoin and the quality of pharmacist's counseling. Patients and Methods: A covert simulated patient (SP) methodology was used in which a trained female researcher, who was 25 years old, played the patient's role through this cross-sectional study by visiting community pharmacies and requesting isotretinoin capsules through a controlled prescription. A data form was used to collect the information following each pharmacy visit by asking about medical/family history and providing comprehensive counseling about the most common adverse effects, proper use instructions, and the importance of adherence to medication. The pharmacists, who did not initiate counseling, were prompted by the SP. Results: The pharmacists in 400 pharmacies who agreed to participate were visited by the SP. Only 7 (2%) pharmacists provided a complete assessment of patient eligibility for using isotretinoin with comprehensive counseling. Most of the pharmacists (84%) provided incomplete assessment as indicated by the overall score. Only 11 (3%) pharmacists asked the six crucial questions for the assessment of patient eligibility. On prompting, only 6 (2%) pharmacists provided complete counseling about the expected adverse effects. The most frequently provided adverse effect was dry skin, specifically dry lips (71.8%). A minority of 108 (27%) pharmacists provided education about the importance of using contraception during isotretinoin therapy. A complete level of counseling was provided by 125 (31.3%) pharmacists regarding the lab tests that the SP needs to undergo during therapy. Female pharmacists were more likely to provide counseling about the pregnancy test (mean=134, p=0.001). Conclusion: Suboptimal level of the patient's assessment was revealed with poor educational counseling by the community pharmacists. New strategies are needed to improve pharmaceutical care services in the UAE.

show abstract

“…It carries many unfavorable side effects such as teratogenicity, abnormal lipid profile, psychiatric issues, and dryness, which is the most common complaint among users [7]. Due to its teratogenicity, females of childbearing age must be advised to be on two or more contraception methods while on treatment [8]. In addition, regular monitoring and patient follow-up are recommended.…”

Section: Introductionmentioning

confidence: 99%

Females' Knowledge and Use of Isotretinoin (Roaccutane) in the Western Region of Saudi Arabia

Bakheet¹,

Alghanemi²,

Alsiyoufi³

et al. 2020

Cureus

View full text Add to dashboard Cite

Dermatologists’ level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential

Abstract: Some dermatologists still do not follow the recommendations for isotretinoin prescription to FCBP. This needs to be corrected, especially in countries with restrictions on abortion.

Cited by 10 publications

References 15 publications

Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study

Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study

<p>Proper Counseling and Dispensing of Isotretinoin Capsule Products by Community Pharmacists in UAE: A Simulated Patient Study</p>

Females' Knowledge and Use of Isotretinoin (Roaccutane) in the Western Region of Saudi Arabia

Contact Info

Product

Resources

About